Erythromycin Ethylsuccinate is a Oral Granule, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Ani Pharmaceuticals, Inc.. The primary component is Erythromycin Ethylsuccinate.
| Product ID | 62559-630_25635db5-a227-445d-850a-a98c5f4772ff |
| NDC | 62559-630 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Erythromycin Ethylsuccinate |
| Generic Name | Erythromycin Ethylsuccinate |
| Dosage Form | Granule, For Suspension |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-03-25 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA062055 |
| Labeler Name | ANI Pharmaceuticals, Inc. |
| Substance Name | ERYTHROMYCIN ETHYLSUCCINATE |
| Active Ingredient Strength | 200 mg/5mL |
| Pharm Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-03-25 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA062055 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2019-03-25 |
| Ingredient | Strength |
|---|---|
| ERYTHROMYCIN ETHYLSUCCINATE | 200 mg/5mL |
| SPL SET ID: | 3d80f96e-3bbe-4fa5-89a8-694c61dd5e8f |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |